IGM Biosciences Correlations

IGMS Stock  USD 1.28  0.01  0.79%   
The current 90-days correlation between IGM Biosciences and Dyne Therapeutics is 0.21 (i.e., Modest diversification). The correlation of IGM Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

IGM Biosciences Correlation With Market

Modest diversification

The correlation between IGM Biosciences and DJI is 0.27 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding IGM Biosciences and DJI in the same portfolio, assuming nothing else is changed.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IGM Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For more information on how to buy IGM Stock please use our How to Invest in IGM Biosciences guide.

Moving against IGM Stock

  0.33TRV The Travelers CompaniesPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
AKROSTOK
EWTXDYN
CGEMDYN
ALXOCGEM
MLYSDYN
CGEMEWTX
  
High negative correlations   
SWTXEWTX
SWTXALXO
ALXOSTOK
AKROALXO
SWTXDYN
ALXOMLYS

Risk-Adjusted Indicators

There is a big difference between IGM Stock performing well and IGM Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze IGM Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

IGM Biosciences Corporate Management

TS HarigopalSenior OperationsProfile
Faraz SiddiquiSenior OperationsProfile
Angus SinclairSenior ImmunoOncologyProfile
Elizabeth JDSenior PropertyProfile
Elaine SapinosoSenior QualityProfile
Misbah CPAChief OfficerProfile
Lisa DeckerChief OfficerProfile